| 1571 |
DAPAGLIFLOZIN TABLETS 10 MG |
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE EQ.TO DAPAGLIFLOZIN 10 MG |
TABLET |
ALU-ALU BLISTER |
FOR THE TREATMENT OF TYPE 2 DIABETES IN ADULT AGED 18 YEARS AND OLDER WITH TYPE 2 DIABETES MELLITUS TO IMPROVE GLYCEMIC CONTROL AS MONOTHERAPY AND AS ADD-ON COMBINATION, AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULT WITH TYPE 2 DIABETES MELLITUS. |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
SWISS GARNIER LIFE SCIENCES |
INDIA |
CERTIFICATE RELEASED |
07 I 5787/24 |
26-Jul-2024 |
25-Jul-2027 |
View |
| 1572 |
DERISE 25 |
DARBEPOETIN ALFA (R-DNA ORIGIN) 25 MCG/0.42ML |
SOLUTION FOR INJECTION |
PRE-FILLED SYRINGE |
FOR THE TREATMENT OF ANEMIA WITH CHRONIC RENAL FAIILURE INCLUDING PATIENTS ON DIALYSIS AND PATIENTS NOT ON DIALYSIS AND TREATMENT OF SYMPTOMATIC ANEMIA IN ADULT CANCER PATIENTS WITHNON-MYELOID MALIGNANCEIES RECEIVING CHEMOTHERAPY |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
HETERO BIOPHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5526/23 |
15-MAY-2023 |
14-MAY-2026 |
View |
| 1573 |
DERISE 40 |
DARBEPOETIN ALFA (R-DNA ORIGIN) 40MCG/0.40 ML |
SOLUTION FOR INJECTION |
PRE-FILLED SYRINGE |
FOR THE TREATMENT OF ANEMIA WITH CHRONIC RENAL FAIILURE INCLUDING PATIENTS ON DIALYSIS AND PATIENTS NOT ON DIALYSIS AND TREATMENT OF SYMPTOMATIC ANEMIA IN ADULT CANCER PATIENTS WITHNON-MYELOID MALIGNANCEIES RECEIVING CHEMOTHERAPY |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
HETERO BIOPHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5527/23 |
19-MAY-2023 |
18-MAY-2026 |
View |
| 1574 |
EZEMIBE |
EZETIMIBE 10 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
PRIMARY HYPERCHOLESTEROLAEMIA, PREVENTION OF CARDIOVASCULAR EVENTS, HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
MEDIWIN PHARMACEUTICALS |
INDIA |
CERTIFICATE RELEASED |
07 I 5566/23 |
07-JUL-2023 |
06-JUL-2026 |
View |
| 1575 |
KETOROSE |
EACH FILM COATED TABLET CONTAINS: ALPHA KETOANALOGUE OF ISOLEUCINE CALCIUM SALT 67 MG, ALPHA KETOANALOGUE OF LEUCINE CALCIUM SALT 101 MG, ALPHA KETOANALOGUE OF PHENYLALANINE CALCIUM SALT 68 MG, ALPHA KETOANALOGUE OF VALINE CALCIUM SALT 86 MG, ALPHA HYDROXYANALOGUE OF METHIONINE CALSIUM SALT 59 MG, L-LYSINE ACETATE USP 105 MG, L-THREONINE USP 53 MG, L-TRYPTOPHAN USP 23 MG, L-HISTIDINE USP 38 MG, L-TYROSINE USP 30 MG, TOTAL NITROGEN CONTENT 36 MG, CALSIUM CONTENT 0.05 G |
TABLET |
ALU-ALU BLISTER |
PREVENTION AND THERAPY OF DAMAGES DUE TO FAULTY OR DEFICIENT PROTEIN METABOLISM IN CHRONIC RENAL INSUFFICIENCY IN CONNECTION WITH LIMITED PROTEIN IN FOOD OF 40G PER DAY (FOR ADULTS) AND LESS., I.G. GENERALLY IN PATIENTS WITH A GLOMERULAR FILTRATION RATE BELOW 25 ML/MIN OR BETWEEN 5 AND ABOUT 15 ML/MIN |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
PHAROSE REMEDIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5750/24 |
24-MAY-2024 |
23-MAY-2027 |
View |
| 1576 |
K-GO |
CALCIUM POLYSTYRENE SULFONATE BP 5G |
POWDER |
SACHET |
IN PATIENT WITH HYPERKALEMIA ASSOCIATED WITH ANURIA OR SEVERE OLIGURIA, IT REDUCES SERUM LEVELS OF POTASSIUM AND REMOVES EXCESS POTASSIUM FROM THE BODY. INDICATED IN ALL STATES OF HYPERKALEMIA DUE TO ACUTE AND CHRONIC RENAL FAILURE |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
PHAROSE REMEDIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
07 I 5567/23 |
07-JUL-2023 |
06-JUL-2026 |
View |
| 1577 |
K-GO |
CALCIUM POLYSTYRENE SULFONATE BP 15G |
POWDER |
SACHET |
IN PATIENT WITH HYPERKALEMIA ASSOCIATED WITH ANURIA OR SEVERE OLIGURIA, IT REDUCES SERUM LEVELS OF POTASSIUM AND REMOVES EXCESS POTASSIUM FROM THE BODY. INDICATED IN ALL STATES OF HYPERKALEMIA DUE TO ACUTE AND CHRONIC RENAL FAILURE |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
PHAROSE REMEDIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
07 I 5568/23 |
07-JUL-2023 |
06-JUL-2026 |
View |
| 1578 |
PAMERA 40 |
ADALIMUMAB (R-DNA ORIGIN) 40 MG/ 0.8 ML |
SOLUTION FOR INJECTION |
PRE-FILLED SYRINGE |
RHEUMATOID ARTHRITIS, JUVENILE IDIOPATHIC ARTHRITIS, AXIAL SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, PSORIASIS, PAEDIATRIC PLAQUE PSORIASIS, HIDRADENITIS SUPPURATIVA, CROHN'S DISEASE, PAEDIATRIC CROHN'S DISEASE, ULCERATIVE COLITIPS, UVEITIS |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
HETERO BIOPHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5528/23 |
15-MAY-2023 |
14-MAY-2026 |
View |
| 1579 |
RENAGLOB |
ALPHA KETOANALOGUE TO ISOLEUCIN (CALCIUM SALT) 67 MG, ALPHA KETOANALOGUE TO LEUCIN (CALCIUM SALT) 101 MG, ALPHA KETOANALOGUE TO PHENYLALANINE (CALCIUM SALT) 68 MG, ALPHA KETOANALOGUE TO VALINE (CALCIUM SALT) 86 MG, ALPHA HYDROXYANALOGUE TO METHIONINE 59 MG (CALCIUM SALT) , L-LYSINE ACETATE 105 MG, L-THREONINE 53 MG, L-TRYPTOPHAN 23 MG, L-HISTIDINE 38 MG, L- TYROSINE 30 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
PREVENTION AND THERAPY OF DAMAGE DUE TO CKD TILL GRF IS 15 ML/MIN., I.E STAGES II, III AND IV OF CKD |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
GLOBELA PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5821/24 |
16-DEC-2024 |
15-DEC-2029 |
View |
| 1580 |
RILAST 100 |
RITUXIMAB(R-DNA ORIGIN) 100 MG/ 10ML |
SOLUTION FOR INJECTION |
VIAL |
NON HODGKIN'S LYMPHOMA, PATIENTS WITH DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA, RHEUMATOID ARTHRITIS, GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGITIS |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
HETERO BIOPHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5365/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
